Biohaven (BHVN) Net Cash Flow (2021 - 2026)

Biohaven has disclosed Net Cash Flow across 6 years of filings, most recently posting $44.3 million for Q1 2026.

• Net Cash Flow for Q1 2026 came in at $44.3 million, up 35633.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $174.4 million (up 306.8% YoY), and the FY2025 annual result was $130.2 million, up 187.03% from the prior year.
• Net Cash Flow came in at $44.3 million for Q1 2026 at Biohaven, roughly flat from $44.4 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $190.8 million in Q4 2022 to a low of -$154.3 million in Q3 2024.
• The 5-year median for Net Cash Flow is $14.4 million (2024), against an average of $11.8 million.
• Across the five-year window, Net Cash Flow tumbled 376.48% in 2023 and surged 35633.87% in 2026, its largest moves.
• Biohaven's Net Cash Flow stood at $190.8 million in 2022, then tumbled by 33.72% to $126.4 million in 2023, then sank by 88.58% to $14.4 million in 2024, then surged by 207.55% to $44.4 million in 2025, then slipped by 0.19% to $44.3 million in 2026.
• The last three Net Cash Flow figures came in at $44.3 million (Q1 2026), $44.4 million (Q4 2025), and $19.4 million (Q3 2025), per Business Quant data.